Clinical Photobiomodulation Interest Group or CPIG is a new initiative from the Brain Mind & Memory Institute aiming to foster a  community of  neuromodulation practitioners interested to learn about using transcranial photobiomodulation  for improving brain health and performance. 

Photobiomodulation (PBM), often referred to as low-level light therapy, is a non-invasive technique that utilizes low-intensity light to activate cellular processes within living tissues. When applied to the brain, through a method known as transcranial photobiomodulation (tPBM), it exhibits the potential to improve cognitive function, alleviate symptoms of neurological disorders, and foster overall brain well-being. This emerging area of research suggests that exposing the brain to specific wavelengths of light in a controlled manner can offer therapeutic advantages and could have implications for conditions such as Alzheimer's disease, depression, and traumatic brain injuries. 

This group is for clinicians and researchers interested in clinical application of neuro photobiomodulation and how use neuromarkers from EEG and Event Related potentials for selecting optimal and safe protocols for photobiomodulation in different brain conditions and for better well-being and performance.

To join the group you need to be a member of BMMI

You can  join our membership join here :   

Our first inaugural meeting is scheduled for 

March 09 2024, 10:00-11:30 am AEDT (Sydney)

or March 08, 15:00 -16:30 pm US Pacific time

Please register here

Meeting agenda 

We have secured support from the team of Neuronic, a company that  makes Neuradiant 1070 photobiomodulation device , which is becoming very popular with clinicians and users. 

Maria Da Costa and Nicole Greig from Neuronic will help to launch our  group with  an introduction to PBM technology. 

Here are details :

  1.  Welcome to the group. Goals and plans 
  2. Introduction to Transcranial Photobiomodulation by Maria da Costa
  3. Nicole Greig will be going over the Neuradiant 1070 device, also  how they develop protocols using symptoms and qEEG, reviewing a case study, and explaining clinical integration of PBM in various settings.


Maria Da Costa 

Maria graduated from Nova Southeastern University with a bachelor’s in Biology and a minor in Psychology. During her time as a Student Researcher at NSU Rumbaugh-Goodwin Institute for Cancer Research, she conducted controlled experiments using various laboratory techniques, such as gel electrophoresis, Western Blot, and qPCR. Maria contributed to research projects, including studying cell cycle arrest induced by histone acetylation and exploring epigenetic modifications in genes associated with tumorigenesis. 

Upon graduation from NSU, Maria worked in the Department of Immunology and Microbiology at the University of Miami. There, she specialized in cultivating primary intestinal mice organoids, maintained precise records, and conducted experiments related to immunotherapy treatments. She also managed transgenic mouse databases and summarized experimental data. 

At Neuronic, Maria's role as Research Coordinator consists of managing a wide spectrum of research projects involving the Neuradiant 1070 PBM device. This includes overseeing collaborations with clinics and researchers interested in further expanding the PBM research field and orchestrating large-scale clinical trials, both within and outside Neuronic. She leads the design and execution of Neuronic’s first clinical trial, dedicated to assessing the impact of the Neuradiant device on individuals with Mild Cognitive Impairment (MCI). Maria also handles communications with regulatory entities such as the FDA to secure a path towards obtaining medical device licenses.

Nicole Greig 

Nicole Greig graduated with her BSc in Behavioural Neuroscience from the University of British Columbia (UBC), with courses focusing on aging, cognition, addiction, psychiatric disorders and neurobiology. During her time at UBC, she worked in a lab focused on mental health outcomes for diabetics, and another lab that studied the relationship between aging, cognition and mobility. Most recently, she worked in a Neurofeedback and TMS clinic.

She is currently a consultant at Neuronic that works with clients with varying conditions to use photobiomodulation optimally. She uses qEEGs to guide protocol creation and works directly with clients to achieve their goals. She is also involved in the current clinical trial by Neuronic, studying mild cognitive impairment, and is integrated in sales and marketing efforts as well. 


Neha Bhutani, PhD

Neha holds a PhD in Neuroscience focusing on neural control of movement planning and execution. As the founder of REVAI, she worked on creating a wearable stimulation device to enhance cognitive functions. Motivated by the mission of improving the quality of life of people with neurological and neuropsychiatric disorders, she brings diverse perspectives and experiences to Neuronic from her academic and entrepreneurial background. As Scientific and Clinical Director at Neuronic, Neha is working on designing the clinical trials and the regulatory approvals for the Neuronic device. 

We are going to have regular meetings this year with fantastic presenters. 

If you would like to be a member of this group please first join BMMI as a member and then sunscribe to the group  by filling the form below*

*The link only works when you logged in as a member. 

Sorry, subscription is currently disabled. Please contact system administrator.
© Brain Mind & Memory Institute
Powered by Wild Apricot Membership Software